PTDM is a prevalent side effect of solid organ transplantation and is a key predictor of early and late graft failure, as well as early and late mortality. Immediate post-transplant hyperglycemia necessitates active monitoring and management with insulin therapy, and if it persists once the patient is medically stable, it may be possible to taper or discontinue insulin and start oral hypoglycemic therapy. Treatment aims and approaches for PTDM should be the same as for type 2 diabetes once it is established. For more details please contact us! 9811459842.
